ESR1 and breast carcinoma: Therefore, our results indicate that WBP2 expression is highly correlated with MDR1 expression in chemotherapy treatment breast cancer patients, and WBP2, ER and MDR1 gene signature might be served as a predictive marker for resistant to chemotherapy in breast cancer patients.